Login / Signup

Early intervention with biological therapy in Crohn´s disease - how early is early?

Joana RevésAndré MascarenhasMaria José TemidoBárbara MorãoCatarina Neto NascimentoAna Rita FrancoRaquel R MendesCarolina PalmelaCristina ChagasPedro Narra FigueiredoLuísa GlóriaFrancisco PortelaJoanna Torres
Published in: Journal of Crohn's & colitis (2023)
Starting anti-TNF therapy within the first 24 months after diagnosis was associated with a low rate of CD-related complications and high rates of clinical and endoscopic remission, although we found no differences with earlier initiation within this window of opportunity.
Keyphrases
  • randomized controlled trial
  • rheumatoid arthritis
  • stem cells
  • disease activity
  • mesenchymal stem cells
  • systemic lupus erythematosus
  • bone marrow